Tang, Y., Liu, X., Ye, W., Wang, X., Wei, X., Du, Y., . . . Gong, Y. (2025). METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC‐1α–MAPK Pathway and PGC‐1α–Antioxidant System Axis. Cancer Medicine, 14(7), . https://doi.org/10.1002/cam4.70771
Chicago-referens (17:e uppl.)Tang, Yuqian, Xiaoyan Liu, Wu Ye, Xiaojia Wang, Xiaoyu Wei, Yiwen Du, Ying Zhang, och Yuping Gong. "METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC‐1α–MAPK Pathway and PGC‐1α–Antioxidant System Axis." Cancer Medicine 14, no. 7 (2025). https://doi.org/10.1002/cam4.70771.
MLA-referens (9:e uppl.)Tang, Yuqian, et al. "METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC‐1α–MAPK Pathway and PGC‐1α–Antioxidant System Axis." Cancer Medicine, vol. 14, no. 7, 2025, https://doi.org/10.1002/cam4.70771.
